BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 13, 2015
View Archived Issues
Corbus Pharmaceuticals receives IND clearance from FDA to begin phase II trials of Resunab
Read More
Canagliflozin provides greater reduction in A1C and body weight than sitagliptin
Read More
Phase I results reported on novel peptide deformylase inhibitor, IDP-73152 mesylate
Read More
HM-10560A found safe in growth hormone deficiency patients
Read More
AGTC files IND to study gene therapy for X-linked retinoschisis
Read More
CureVac patents new rabies vaccine
Read More
LG Life Sciences discloses necrosis and apoptosis inhibitors
Read More
Shanghai Bioduro Biologics patent describes FFAR1 agonists
Read More
Allergen completes series B financing round to advance drug development portfolio
Read More
Taiho Pharmaceutical divulges novel EGFR inhibitors
Read More
Toyama Chemical reports development of antifungal agents
Read More
BriaCell Therapeutics submits phase I/II protocol to the FDA
Read More
GlaxoSmithKline describes second-generation HIV-1 maturation inhibitor
Read More
Galectin Therapeutics to conduct phase II trial of GR-MD-02 in NASH
Read More
Thyroid hormone receptor activation induces white adipose tissue conversion
Read More
Kura Oncology enters into agreement with Janssen Pharmaceutica for tipifarnib
Read More
Neuralstem reports topline results from phase II NSI-566 trial
Read More
Endo makes proposal to acquire Salix
Read More
NIH grant supports RetroVirox's work in HIV
Read More
Evotec and Second Genome establish microbiome discovery and development collaboration
Read More
Novartis's LCZ-696 awarded priority review by Health Canada
Read More
Epizyme regains ex-Japanese rights to EPZ-6438 from Eisai
Read More
Meiji Seika Pharma discontinues development of ME-3301
Read More
AB Science reports results from phase Ib/II study of masitinib in triple-negative breast cancer
Read More
FDA accepts resubmitted NDA for daclatasvir
Read More